Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation: One-Year Data from the Global ETNA-AF Program

Non-recommended dosing occurs in ~25–50% of non-vitamin K antagonist oral anticoagulant prescriptions, with limited data for edoxaban. We analyzed edoxaban dosing patterns in atrial fibrillation patients from the Global ETNA-AF program, relating patterns to baseline characteristics and 1-year clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Tze-Fan, Unverdorben, Martin, Kirchhof, Paulus, Koretsune, Yukihiro, Yamashita, Takeshi, Crozier, Robert A., Pecen, Ladislav, Chen, Cathy, Borrow, Amanda P., De Caterina, Raffaele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003604/
https://www.ncbi.nlm.nih.gov/pubmed/36902656
http://dx.doi.org/10.3390/jcm12051870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003604/
https://www.ncbi.nlm.nih.gov/pubmed/36902656
http://dx.doi.org/10.3390/jcm12051870

Ejemplares similares